BRPI0208456B8 - métodos para cultura de circovírus - Google Patents

métodos para cultura de circovírus

Info

Publication number
BRPI0208456B8
BRPI0208456B8 BRPI0208456A BR0208456A BRPI0208456B8 BR PI0208456 B8 BRPI0208456 B8 BR PI0208456B8 BR PI0208456 A BRPI0208456 A BR PI0208456A BR 0208456 A BR0208456 A BR 0208456A BR PI0208456 B8 BRPI0208456 B8 BR PI0208456B8
Authority
BR
Brazil
Prior art keywords
methods
circovirus
culture
circoviruses
culturing
Prior art date
Application number
BRPI0208456A
Other languages
English (en)
Other versions
BRPI0208456B1 (pt
BR0208456A (pt
Inventor
A Babiuk Lorne
Willson Philip
Liu Qiang
K Tikoo Suresch
Original Assignee
Univ Saskatchewan
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Saskatchewan filed Critical Univ Saskatchewan
Publication of BR0208456A publication Critical patent/BR0208456A/pt
Publication of BRPI0208456B1 publication Critical patent/BRPI0208456B1/pt
Publication of BRPI0208456B8 publication Critical patent/BRPI0208456B8/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/10011—Adenoviridae
    • C12N2710/10311—Mastadenovirus, e.g. human or simian adenoviruses
    • C12N2710/10322—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
    • C12N2750/00011—Details
    • C12N2750/10011—Circoviridae
    • C12N2750/10021—Viruses as such, e.g. new isolates, mutants or their genomic sequences
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
    • C12N2750/00011—Details
    • C12N2750/10011—Circoviridae
    • C12N2750/10041—Use of virus, viral particle or viral elements as a vector
    • C12N2750/10043—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
    • C12N2750/00011—Details
    • C12N2750/10011—Circoviridae
    • C12N2750/10051—Methods of production or purification of viral material
    • C12N2750/10052—Methods of production or purification of viral material relating to complementing cells and packaging systems for producing virus or viral particles

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Virology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)

Abstract

"métodos para cultura de circovírus". a presente invenção refere-se a métodos para cultura de circovírus e em particular circovírus de suíno. a presente invenção proporciona composições e métodos para cultura de circovírus de suíno em células de mamífero que expressam a função e1 de adenovírus de mamífero.
BRPI0208456A 2001-03-27 2002-03-27 métodos para cultura de circovírus BRPI0208456B8 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US27917301P 2001-03-27 2001-03-27
PCT/CA2002/000413 WO2002077210A2 (en) 2001-03-27 2002-03-27 Methods to culture circovirus

Publications (3)

Publication Number Publication Date
BR0208456A BR0208456A (pt) 2004-03-02
BRPI0208456B1 BRPI0208456B1 (pt) 2016-10-18
BRPI0208456B8 true BRPI0208456B8 (pt) 2021-05-25

Family

ID=23067939

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0208456A BRPI0208456B8 (pt) 2001-03-27 2002-03-27 métodos para cultura de circovírus

Country Status (24)

Country Link
US (3) US6794163B2 (pt)
EP (1) EP1379671B1 (pt)
JP (1) JP4038127B2 (pt)
KR (1) KR100876629B1 (pt)
CN (2) CN1309836C (pt)
AT (1) ATE430807T1 (pt)
AU (1) AU2002244584B2 (pt)
BR (1) BRPI0208456B8 (pt)
CA (1) CA2442135C (pt)
CY (1) CY1109267T1 (pt)
CZ (1) CZ304525B6 (pt)
DE (1) DE60232234D1 (pt)
DK (1) DK1379671T3 (pt)
ES (1) ES2324466T3 (pt)
HU (1) HU228065B1 (pt)
MX (1) MXPA03008810A (pt)
MY (2) MY146518A (pt)
PL (1) PL202951B1 (pt)
PT (1) PT1379671E (pt)
RU (2) RU2312142C2 (pt)
SK (1) SK287969B6 (pt)
UA (1) UA82647C2 (pt)
WO (1) WO2002077210A2 (pt)
ZA (1) ZA200307517B (pt)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040062775A1 (en) * 1997-12-05 2004-04-01 Agence Francaise De Securite Sanitaire Des Aliments Circovirus sequences associated with piglet weight loss disease (PWD)
FR2772047B1 (fr) * 1997-12-05 2004-04-09 Ct Nat D Etudes Veterinaires E Sequence genomique et polypeptides de circovirus associe a la maladie de l'amaigrissement du porcelet (map), applications au diagnostic et a la prevention et/ou au traitement de l'infection
ES2170622B1 (es) * 1999-12-03 2004-05-16 Consejo Superior De Investigaciones Cientificas Clones y vectores infectivos derivados de coronavirus y sus aplicaciones.
UA82647C2 (uk) * 2001-03-27 2008-05-12 Юниверсити Оф Саскачеван Спосіб культивування цирковірусу ссавця
US20030096377A1 (en) * 2001-06-28 2003-05-22 Virginia Tech Intellectual Properties, Inc. Differential PCR-RFLP assay for detecting and distinguishing between nonpathogenic PCV-1 and pathogenic PCV-2
US7279166B2 (en) 2001-12-12 2007-10-09 Virginia Tech Intellectual Properties, Inc. Chimeric infectious DNA clones, chimeric porcine circoviruses and uses thereof
US7276353B2 (en) * 2001-12-12 2007-10-02 Virginia Tech Intellectual Properties, Inc. Chimeric infectious DNA clones, chimeric porcine circoviruses and uses thereof
US7700285B1 (en) 2005-12-29 2010-04-20 Boehringer Ingelheim Vetmedica, Inc. PCV2 immunogenic compositions and methods of producing such compositions
US7833707B2 (en) * 2004-12-30 2010-11-16 Boehringer Ingelheim Vetmedica, Inc. Methods of overexpression and recovery of porcine circovirus type 2 ORF2
UA95602C2 (ru) 2004-12-30 2011-08-25 Берингер Ингельхейм Ветмедика, Инк. Иммуногенная композиция цвс2 и способы приготовления такой композиции
US8834891B2 (en) 2005-03-14 2014-09-16 Boehringer Ingelheim Vetmedica, Inc. Immunogenic compositions comprising Lawsonia intracellularis
DK3127551T3 (da) 2005-12-29 2020-10-12 Boehringer Ingelheim Animal Health Usa Inc Pcv2-immunogen-sammensætning til at mindske kliniske symptomer i grise
EP1968630B1 (en) 2005-12-29 2018-01-24 Boehringer Ingelheim Vetmedica, Inc. Multivalent pcv2 immunogenic compositions
US20100129397A1 (en) * 2006-12-11 2010-05-27 Boehringer Ingelheim Vetmedica, Inc. Effective method of treatment of porcine circovirus and lawsonia intracellularis infections
PT2481420T (pt) * 2006-12-15 2019-05-31 Boehringer Ingelheim Animal Health Usa Inc Vacina para porcos anti-pcv2 de dose única
EP1941903A1 (en) * 2007-01-03 2008-07-09 Boehringer Ingelheim Vetmedica Gmbh Prophylaxis and treatment of PRDC
EP1958644A1 (en) 2007-02-13 2008-08-20 Boehringer Ingelheim Vetmedica Gmbh Prevention and treatment of sub-clinical pcvd
AU2007353480B2 (en) * 2007-05-11 2013-09-19 Temasek Life Sciences Laboratory Limited Production of a homogeneous cell line highly permissive to porcine circovirus type 2 (PCV2) infection
WO2008151215A1 (en) * 2007-06-04 2008-12-11 Merial Limited Production of porcine circovirus proteins in plants
US7829274B2 (en) * 2007-09-04 2010-11-09 Boehringer Ingelheim Vetmedica, Inc. Reduction of concomitant infections in pigs by the use of PCV2 antigen
NZ586238A (en) * 2007-12-21 2012-10-26 Wyeth Llc Methods and compositions for immunizing pigs against porcine circovirus
JP2011508595A (ja) * 2007-12-31 2011-03-17 ベーリンガー インゲルハイム フェトメディカ インコーポレイテッド 外来性アミノ酸の挿入を含むｐｃｖ２ｏｒｆ２ウイルス様粒子
US20090317423A1 (en) * 2008-01-23 2009-12-24 Boehringer Ingelheim Vetmedica, Inc. Pcv2 mycoplasma hyopneumoniae immunogenic compositions and methods of producing such compositions
EP2276507A4 (en) * 2008-04-16 2011-11-16 Virginia Tech Intell Prop PCV2GEN-1REP CHIMERIC PORCINIC CIRCOVIRUS AND USES THEREOF
TWI627281B (zh) * 2009-09-02 2018-06-21 百靈佳殷格翰家畜藥品公司 降低ｐｃｖ－２組合物殺病毒活性之方法及具有改良免疫原性之ｐｃｖ－２組合物
EP2528931A4 (en) * 2010-01-25 2013-12-04 Blood Systems Inc CYCLOVIRUS AND USE METHOD THEREFOR
JP6821429B2 (ja) 2013-09-25 2021-01-27 ゾエティス・サービシーズ・エルエルシー Ｐｃｖ２ｂ分岐ワクチン組成物及び使用方法
US9505808B2 (en) 2013-10-02 2016-11-29 Boehringer Ingelheim Vetmedica, Inc. PCV2 ORF2 protein variant and virus like particles composed thereof
WO2016183423A1 (en) 2015-05-14 2016-11-17 Merial Inc. Method for porcine circovirus production and pcv2 vaccines
US10462620B2 (en) * 2016-10-11 2019-10-29 Orion Labs Group communication forwarding to a secondary service
CN114934020B (zh) * 2022-01-30 2024-02-13 山东省滨州畜牧兽医研究院 猪视网膜上皮细胞系及其建立方法和应用

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU729579B2 (en) * 1996-10-23 2001-02-01 Trustees Of The University Of Pennsylvania, The Immunotherapy and improved vaccines
AUPO856097A0 (en) 1997-08-14 1997-09-04 Commonwealth Scientific And Industrial Research Organisation Vector
US6517843B1 (en) * 1999-08-31 2003-02-11 Merial Reduction of porcine circovirus-2 viral load with inactivated PCV-2
FR2781159B1 (fr) * 1998-07-06 2000-10-06 Merial Sas Vaccin circovirus et parvovirus porcin
US7192594B2 (en) 1997-10-03 2007-03-20 Merial Limited Postweaning multisystemic wasting syndrome and porcine circovirus from pigs
US6391314B1 (en) 1997-10-03 2002-05-21 Merial Porcine circoviruses vaccines diagnostic reagents
UA78180C2 (uk) 1997-10-03 2007-03-15 Меріаль Кільцевий вірус свині типу ii, вакцини та діагностичні реагенти
FR2772047B1 (fr) 1997-12-05 2004-04-09 Ct Nat D Etudes Veterinaires E Sequence genomique et polypeptides de circovirus associe a la maladie de l'amaigrissement du porcelet (map), applications au diagnostic et a la prevention et/ou au traitement de l'infection
AU770002B2 (en) 1998-03-13 2004-02-12 University Of Georgia Research Foundation, Inc., The Vaccines against circovirus infections
US6492343B1 (en) 1998-04-15 2002-12-10 University Of Saskatchewan Porcine adenovirus type 3 genome
CA2342979C (en) 1998-09-08 2011-05-10 Brij P. Giri Chemiluminescent 1,2-dioxetanes
AU780822B2 (en) * 1998-11-02 2005-04-21 University Of Saskatchewan Bovine cells expressing adenovirus essential functions for propagation of recombinant adenoviral vectors
FR2789695B1 (fr) 1999-02-11 2003-03-07 Merial Sas Vecteurs et vaccins viraux a base d'adenovirus porcins recombines et replicatifs
US6943152B1 (en) 1999-06-10 2005-09-13 Merial DNA vaccine-PCV
US6497883B1 (en) 1999-06-10 2002-12-24 Merial Porcine circovirus recombinant poxvirus vaccine
CA2413265A1 (en) * 2000-05-03 2001-11-08 University Of Guelph Porcine adenovirus type 5 vector and vaccine
UA82647C2 (uk) 2001-03-27 2008-05-12 Юниверсити Оф Саскачеван Спосіб культивування цирковірусу ссавця

Also Published As

Publication number Publication date
US20070128700A1 (en) 2007-06-07
CN1309836C (zh) 2007-04-11
ZA200307517B (en) 2004-09-27
US6794163B2 (en) 2004-09-21
JP4038127B2 (ja) 2008-01-23
SK12102003A3 (sk) 2004-05-04
WO2002077210A3 (en) 2003-08-21
CA2442135A1 (en) 2002-10-03
CN1840656A (zh) 2006-10-04
RU2312142C2 (ru) 2007-12-10
US20020177216A1 (en) 2002-11-28
ATE430807T1 (de) 2009-05-15
CY1109267T1 (el) 2014-07-02
SK287969B6 (sk) 2012-08-06
HU228065B1 (en) 2012-09-28
PL202951B1 (pl) 2009-08-31
ES2324466T3 (es) 2009-08-07
AU2002244584B2 (en) 2006-12-14
EP1379671B1 (en) 2009-05-06
EP1379671A2 (en) 2004-01-14
KR100876629B1 (ko) 2009-01-07
RU2003131342A (ru) 2005-04-20
CN1840656B (zh) 2010-06-02
UA82647C2 (uk) 2008-05-12
MY148759A (en) 2013-05-31
BRPI0208456B1 (pt) 2016-10-18
CA2442135C (en) 2008-08-19
DK1379671T3 (da) 2009-06-29
RU2007110808A (ru) 2008-09-27
DE60232234D1 (de) 2009-06-18
MY146518A (en) 2012-08-15
BR0208456A (pt) 2004-03-02
KR20040002881A (ko) 2004-01-07
CN1625598A (zh) 2005-06-08
JP2005500822A (ja) 2005-01-13
HUP0500161A3 (en) 2010-01-28
PT1379671E (pt) 2009-07-20
US20050239187A1 (en) 2005-10-27
PL364077A1 (en) 2004-12-13
WO2002077210A2 (en) 2002-10-03
US7560278B2 (en) 2009-07-14
MXPA03008810A (es) 2004-02-17
CZ304525B6 (cs) 2014-06-18
CZ20032584A3 (en) 2004-03-17
HUP0500161A2 (hu) 2005-05-30
US7172899B2 (en) 2007-02-06

Similar Documents

Publication Publication Date Title
BRPI0208456B8 (pt) métodos para cultura de circovírus
Jin et al. Isolation and characterization of human mesenchymal stem cells from gingival connective tissue
DE60009339D1 (de) Zusammensetzung zur gewebsregeneration
GB2427874A (en) Differentiation of stem cells to endoderm and pancreatic lineage
WO2005047524A3 (en) Compositions and methods for inducing cell dedifferentiation
TW200730627A (en) Extracellular matrix components for expansion or differentiation of hepatic progenitors
BRPI0506839A (pt) composições e métodos para induzir a cardiomiogênese
WO2008060541A3 (en) In vitro expansion of postpartum-derived cells using microcarriers
Kanafi et al. Influence of hypoxia, high glucose, and low serum on the growth kinetics of mesenchymal stem cells from deciduous and permanent teeth
CO5601047A2 (es) Metodo de cultivo celular libre de animal
WO2006076627A3 (en) Methods and compositions related to modulating the extracellular stem cell environment
TW200734462A (en) Regulating stem cells
WO2004090096A3 (en) Methods for neural differentiation of embryonic stem cells using protease passaging techniques
HK1063334A1 (en) Compositions and methods useful for hcv infection
HUP0302600A2 (hu) Eljárás petefészektüszők in vitro tenyésztésére
SI1456238T1 (sl) Proizvodnja f(ab)2 fragmentov v sesalskih celicah
Knuth et al. Low oxygen tension is critical for the culture of human mesenchymal stem cells with strong osteogenic potential from haemarthrosis fluid
BRPI0407002A (pt) Células cultivadas que apresentam antìgeno cd14+
Zhan et al. Modulation of rabbit corneal epithelial cells fate using embryonic stem cell extract
DK0898708T3 (da) Interaktion af cyclin D1 og estrogenreceptor og anvendelse deraf i assays
ATE352609T1 (de) Mastzellkulturen aus dem schwein und deren verwendungen
BRPI0517942A (pt) meio de cultura de células isento de soro para células de mamìferos
ATE374243T1 (de) Knorpelzell-kulturmedium und verwendung desselben
TW200722520A (en) Human mensenchymal stem cells and culturing methods thereof
NIKNAM PULP AND FOLLICLE OF THIRD MOLAR TEETH: THE UNIQUE ACCESSIBLE SOURCES OF ADULT STEM CELLS

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]

Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI

B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 18/10/2016, OBSERVADAS AS CONDICOES LEGAIS.

B16C Correction of notification of the grant [chapter 16.3 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 27/03/2002 OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF

B16B Notification of grant cancelled [chapter 16.2 patent gazette]

Free format text: ANULADA A PUBLICACAO CODIGO 16.3 NA RPI NO 2629 DE 25/05/2021 POR TER SIDO INDEVIDA.